The Efficacy of Neuromuscular Electrical Stimulation to Attenuate Muscle Loss
1 other identifier
interventional
15
1 country
1
Brief Summary
Subjects who are hospitalized in the ICU will be included after 24 hours of intubation during their ICU stay. Twice-daily Neuromuscular Electrical Stimulation (NMES) will be performed on one leg for 2x40 min per day to assess muscle fiber size. The investigators hypothesize an attenuated loss in muscle fiber size.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
January 18, 2012
CompletedFirst Posted
Study publicly available on registry
January 31, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedAugust 19, 2015
August 1, 2015
3.2 years
January 18, 2012
August 17, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Change in muscle fiber cross sectional area (CSA)
Muscle fiber cross sectional area (in um2) for type I and II fibers will be analyzed by using immunohistochemistry; the change of muscle fiber CSA over time will be measured
3 hours before and 12 hours after 10 days of twice-daily NMES
Secondary Outcomes (1)
Change in upper leg circumference
3 hours before and 12 hours after 10 days of twice-daily NMES
Study Arms (2)
NMES
EXPERIMENTALThe 'NMES' arm will be treated with NMES.
No NMES
SHAM COMPARATORThe 'No NMES' arm of the experiment will be sham-treated with NMES. The device will be installed, but not used.
Interventions
Neuromuscular Electrical Stimulation of m. quadriceps femoris by using a commercially available muscle stimulator
Sham comparator
Eligibility Criteria
You may qualify if:
- Male
- Age between 18 and 80 years
- Expected sedated time of \>24h
You may not qualify if:
- Spinal Cord Injury
- Arterial operaties on the legs
- Local wounds that prohibit NMES
- Chronic use of corticosteroids
- Intake of certain antithrombotic drugs
- Presence of implantable cardioverter defibrillator and/or pacemaker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jessa Hospital
Hasselt, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
January 18, 2012
First Posted
January 31, 2012
Study Start
January 1, 2012
Primary Completion
April 1, 2015
Last Updated
August 19, 2015
Record last verified: 2015-08